(1) Cover letter
-
The cover letter accompanying the manuscript must specify the type of manuscript and include statements on ethical issues and conflicts of interest, and complete contact information for the corresponding author. For case report, the authors must state that a written informed consent was obtained from the patient or legal guardian in the cover letter. The cover letter should include the following statement: "All authors have read and approved the submitted manuscript, the manuscript has not been submitted elsewhere nor published elsewhere in whole or in part, except as an abstract (if relevant)." The cover letter may include the names of potential reviewers (e-mail addresses are required). However, the Editors cannot always guarantee assignment of a particular reviewer to a manuscript.
(2) Title page
-
The title page should contain the following information:
- The full title of the manuscript, not to exceed 120 characters.
- A shortened version of the title, no more than 50 characters long (including spaces), as a running title.
- The full names of all authors. Authors should be limited to those individuals who contributed in an important manner to the study design, data collection and analysis, or writing of the paper.
- The department and institution where work was performed, as well as the affiliations of the individual authors.
- Name, address, and phone and fax numbers, and e-mail address of the corresponding author to whom communications regarding the manuscript should be directed.
- Total word count of Abstract, and total word count including all parts of the manuscript (i.e., title page, abstract, main body of text, acknowledgments, sources of funding, disclosures, references, figure legends, and tables).
(3) Abstract
-
The content of the abstract should be in order of Background, Methods, Results, Conclusion, and Key Words. Each heading should be separated, and within 5 Key Words should be recorded on the bottom of the abstract, where the words should be from Medical Subject Headings (MeSH) of the Index Medicus. For abstract of case report, the abstract is composed in one paragraph without dividing into above headings (background, methods, results, and conclusion).
(4) Introduction
-
The purpose of the study should be concisely and clearly stated, and description of the background should only contain what is related to the purpose. For a case report, no title of “introduction” is needed, and only general background and meaning related to the case should be briefly stated.
(5) Subjects and methods
-
Subjects and methods of the study should be described in order. Participants, experimental animals, and control group should be clearly specified, and when the method of the experiment is the focus, it should be specifically described to enable reproduction. Especially, method for identifying the target disease should be described. Standards for inclusion and exclusion of the experimental group and control group should be clearly stated. Apparatus and reagents should be labeled of the name with the manufacturing company, city, and country in parenthesis. For statistics, the most commonly used method may be described. However, when unfamiliar method is used or the existing method is used with modification, the method should be briefly introduced with reference to explanation on the reason for trying the new method.
(6) Results
-
Results of the study should be listed clearly in logical point of view. When tables are used, the content does not need to be repeatedly described in the manuscript, and only important and essential points should be clarified.
(7) Discussion
-
The results of the study should be discussed and comparatively analyzed in relation to other studies. New and important observation should be emphasized, and the content of the introduction and result should not be repeatedly mentioned. The meaning of observation and limitation should be described, and the conclusion should be briefly stated at the last paragraph taking the result and purpose of the study in correlation.
(8) Ethics statement
-
It is recommended to describe as a following example: A written informed consent was obtained from the patient for her information on demographic data, medical condition, images, videos, treatment, and prognosis anonymously.
(9) Availability of Data and Material
-
It is recommended to describe as a following example: The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
(10) Author Contributions
-
The corresponding author also takes responsibility for listing coinvestigators with contributions to the study/paper of each author. This section should clearly state each author’s contribution to the paper. Authorship must include and be limited to those who have made substantial contributions toward one or more of the following roles or tasks: conception or design of the work, acquisition of data, data analysis and interpretation, drafting the article, revision of the article critically for important intellectual content, and final approval of the version to be published. The description of author contributions is printed with the article (see the example below).
-
Example: A.B. and C.D. designed the study; E.F. and G.H. were responsible for the data acquisition; C.D. and E.F. analyzed the data; C.D. and I.J. wrote the first draft; A.B., E.F., and I.J. critically reviewed the manuscript; G.H. and I.J supervised the project; All authors read and approved the final manuscript.
-
The contributors who do not qualify for authorship should be in the Acknowledgments section.
(11) Acknowledgments
-
When necessary, acknowledgment for who has contributed to the study but does not suit as an author may be stated. Acknowledgment should be expressed for the contributor’s specific role (for example collection of data, financial support, statistical support, experimental analysis, etc), and the fact of putting his or her name in the acknowledgment should be notified to the contributor for permission.
(12) Sources of Funding
-
Authors must list all sources of research support relevant to the manuscript in this location. If you have no disclosures, please state “None”.
(13) Conflicts of interest
-
Authors must state disclosures at the end of main text and on online when submitting a manuscript. Unless you have relevant conflicts of interest, please state “None”.
(14) References
- References should be numbered serially in the text using numbers as unparenthesized superscripts: 1,2,5-7 When reference is quoted within the manuscript, the name of the author is not recommended to be described.
- There is no limitation to total number of references but making it within 30 references is recommended in original article.
- When citing an article that is accepted but not published it should be specified as ‘in press’.
- The names of journals should use the official abbreviation of Index Medicus.
- Less than or equal to 6 authors should be recorded all, and for greater than or equal to 7 authors, ‘et al.’ is put after the first 6 authors.
- Names of authors are put as last name followed by first name with the first letter in capital.
- It is recorded in a new page in order of citation in the manuscript following the format below.
- What is not exampled below follows the format of “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”.
Article in academic journal
1. Park JH. Ovbiagele B. Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology. 2015;84:50–56.
2. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association, Stroke. 2014;45315–353.
Book
1. Wyllie E. The treatmemt of epilepsy. 2nd ed. Baltimore: Williams & Wilkins, 1997;97-98.
Chapter within a book
1. Calne CB, Duvoision RFC, McGeer E. Speculation on the etiology of Parkinson’s disease. In: Hassler RG, Christ JF. Advances in neurology. 2nd ed. Vol. 40. New York: Raven Press. 1984;353-360.
Electronic data
1. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis. [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1): [24 screens]. Available from http://www.cdc.gov/ncidod/EID/eid.htm.
(15) Tables
- Each table must be submitted as separate files. Tables should be provided as editable text, not as images.
- Tables must be cited in text and numbered according to order of appearance.
- Name of the table should be briefly described in verse or phrase format with the first letters of the words of the table name and content put in capital letters.
- For footnotes, use the following symbols in the indicated sequence: *, †, ‡, §, ∥, ¶, **, ††, and ‡‡. The significance of observations, as determined by appropriate statistical analyses, must be indicated. Expansion of abbreviation should all start with small letters, and semicolons should be put in between abbreviations (i.e., BMI, body mass index; CDU, carotid Doppler ultrasound).
- The significance of observations, as determined by appropriate statistical analyses, must be indicated.
- Reference numbers must be used when citing articles.
(16) Figures
- Figures should be prepared in digital, and each figure should be in separate file upon submission (do not embedded the figures in the Microsoft Word manuscript file).
- Acceptable file formats for figure are JPEG, TIFF, GIF, EPS, or PPT.
- Figures are cited in numerical order (Figure 1, Figure 2, etc.) as they appear in the text.
- For figure composed of many figures (for example Figure 1-A, B, C…), the entire figure should be combined and composed upon submission as one file. Upon combination, the margins should be removed as much as possible, and appropriately composed to a balanced figure so that every single figure shows itself well when printed.
- Since size and resolution of the figure is directly related to the quality of the figure when printed, please follow by the instructions thoroughly. Especially, make sure the size of the figure is not too small.
- Line art should be at least 1200 dpi, and half tone or color figure should be at least 600 dpi.
- Size of the figure can be estimated by actual pixel in photoshop for actual size of the figure, and print size or image size should be greater than actual print size.
- Colored figures should be saved in CMYK (cyan, magenta, yellow, black) file format for submission. (Files saved in RGB format is not acceptable.) Half tone figures may be saved in grayscale mode instead of CMYK.
- Legends for figures must appear on a separate page at the end of the manuscript file (following References).
If the manuscript includes any previously published tables or figures, proof of permission from the copyright holder to republish a figure from any source is required. The permission form should be uploaded as a Supplemental File at the time of submission. All related previously published tables or figures should be cited as references and described in the submitted manuscript along with explanation of how the submitted manuscript differs from the related previously published article.
For units of measure, authors should provide units of measure in International System of Units (SI) units. Authors should refer to the American Medical Association Manual of Style for details regarding SI units for laboratory data.
After uploading documents (cover letter, manuscript, tables, figures, and supplemental data) to the submission website (https://j-nn.org), the system will convert documents to PDF files. It is recommended to submit manuscripts in Microsoft Word documents (.doc files). Before review process, if manuscripts are determined to be incompletely prepared, they can be returned to the authors.